Ardent Health, Inc.

Item 5.07. Submission of Matters to a Vote of Security Holders. Ardent Health, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 20, 2026. At the Annual Meeting, a total of 98,778,826 shares of the Company’s common stock, out of a total of 143,095,662 shares of common stock outstanding and entitled to vote as of the record date for the Annual Meeting, were represented in person or by proxy. Voting results from the Annual Meeting were as follows: 1. The following 11 director nominees were elected to the Company's Board of Directors, as follows: For Withhold Broker Non-Votes ───────────────────────────────────────────────────────────────────────────── Mark Sotir 90,717,572 861,184 7,200,070 Martin J. Bonick 91,240,732 338,024 7,200,070 Peter Bulgarelli 91,267,887 310,869 7,200,070 Peter Bynoe 87,141,918 4,436,838 7,200,070 Suzanne Campion 91,271,694 307,062 7,200,070 Robert A. DeMichiei 91,243,922 334,834 7,200,070 William Goodyear 91,243,902 334,854 7,200,070 Ellen Havdala 86,273,698 5,305,058 7,200,070 Edmondo Robinson 91,328,193 250,563 7,200,070 Rahul Sen 79,335,440 12,243,316 7,200,070 Rob Webb 91,362,871 215,885 7,200,070 2. The stockholders approved on a non-binding advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026, as follows: For Against Abstentions Broker Non-Votes ────────────────────────────────────────────────────────────────── 91,093,535 300,746 184,475 7,200,070 3. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: For Against Abstentions Broker Non-Votes ────────────────────────────────────────────────────────────────── 97,852,830 918,233 7,763 0